| Target Price | $6.12 |
| Price | $1.13 |
| Potential |
441.59%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Fractyl Health 2026 .
The average Fractyl Health target price is $6.12.
This is
441.59%
register free of charge
$10.50
829.20%
register free of charge
$4.85
329.03%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Fractyl Health to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fractyl Health stock has an average upside potential 2026 of
441.59%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.62 | -1.52 |
| 17.77% | 6.17% | |
| P/E | negative |
7 Analysts have issued a Fractyl Health forecast for earnings per share. The average Fractyl Health EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 26 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Aug 28 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 26 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Aug 28 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


